Teva Pharmaceutical Industries Ltd (TEVA)
18.78
+0.34
(+1.82%)
USD |
NYSE |
Nov 04, 13:02
Teva Pharmaceutical Industries Price to Book Value: 3.347 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 3.287 |
| October 31, 2024 | 3.285 |
| October 30, 2024 | 3.312 |
| October 29, 2024 | 3.284 |
| October 28, 2024 | 3.273 |
| October 25, 2024 | 3.189 |
| October 24, 2024 | 3.251 |
| October 23, 2024 | 3.280 |
| October 22, 2024 | 3.275 |
| October 21, 2024 | 3.239 |
| October 18, 2024 | 3.198 |
| October 17, 2024 | 3.200 |
| October 16, 2024 | 3.210 |
| October 15, 2024 | 3.234 |
| October 14, 2024 | 3.072 |
| October 11, 2024 | 3.073 |
| October 10, 2024 | 3.102 |
| October 09, 2024 | 3.159 |
| October 08, 2024 | 3.123 |
| October 07, 2024 | 3.079 |
| October 04, 2024 | 3.116 |
| October 03, 2024 | 3.096 |
| October 02, 2024 | 3.111 |
| October 01, 2024 | 3.148 |
| September 30, 2024 | 3.210 |
| Date | Value |
|---|---|
| September 27, 2024 | 3.111 |
| September 26, 2024 | 3.160 |
| September 25, 2024 | 3.111 |
| September 24, 2024 | 3.159 |
| September 23, 2024 | 3.157 |
| September 20, 2024 | 3.120 |
| September 19, 2024 | 3.164 |
| September 18, 2024 | 3.186 |
| September 17, 2024 | 3.180 |
| September 16, 2024 | 3.219 |
| September 13, 2024 | 3.280 |
| September 12, 2024 | 3.209 |
| September 11, 2024 | 3.200 |
| September 10, 2024 | 3.121 |
| September 09, 2024 | 3.171 |
| September 06, 2024 | 3.221 |
| September 05, 2024 | 3.284 |
| September 04, 2024 | 3.378 |
| September 03, 2024 | 3.300 |
| August 30, 2024 | 3.362 |
| August 29, 2024 | 3.337 |
| August 28, 2024 | 3.307 |
| August 27, 2024 | 3.342 |
| August 26, 2024 | 3.314 |
| August 23, 2024 | 3.307 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5245
Minimum
Mar 18 2020
3.378
Maximum
Sep 04 2024
1.342
Average
1.123
Median
Oct 09 2020
Price to Book Value Benchmarks
| Amicus Therapeutics Inc | 25.76 |
| Compugen Ltd | 2.563 |
| Pluri Inc | 273.51 |
| Can Fite Biofarma Ltd | 5.410 |
| BiomX Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 1.300 |
| Price to Free Cash Flow | 31.19 |
| Price | 18.78 |
| Earnings Yield | -2.08% |
| Market Cap | 21.28B |
| Operating PE Ratio | 6.114 |
| Normalized PE Ratio | 12.01 |